Searched for
BIOCON USA
Sun Pharma, Wockhardt & other pharma stocks crack up to 9% as Trump announces 100% tariff on imported patented drugsPharma stocks declined following Donald Trump's tariff announcement. Wockhardt experienced the biggest drop. Sun Pharma also hit a 52-week ...- Biocon inaugurates first manufacturing facility in USBiocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Fo...
- Govt grants sanction to prosecute joint drugs controller S Eswara Reddy in Biocon Biologics bribery caseEswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics' Associate Vice President L Praveen Kumar, and Synergy ...
- Biocon Q4 Results: Profit declines 4% to Rs 283 crConsolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period, it...
- Biocon Biologics set to reap biosimilar insulin glargine opportunity in USDrugmaker Biocon is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and pr...
- C-CAMP launches fourth edition of bio-entrepreneurship competitionNBEC, India’s largest and most prestigious national competition for bio entrepreneurs is held by C-CAMP every year to attract, identify and...
- Why Indian pharma needs more expats on boardsExpats at the helm can help improve corporate governance and transparency
- C-CAMP launches third edition of National Biotech entrepreneurship contestThis year's competition was unveiled by Renu Swarup, Secretary, Department of Biotechnology, and Manish Diwan, Head, SPED, BIRAC.
- CLSA retains sell rating on BioconThe company's consolidated revenue from operations rose 2 per cent to Rs 969 crore in the quarter.
- Pharma stocks tank on fears of poor Q4 nosAnalysts also do not seem optimistic about the peers of Sun Pharma.
- Kiran Mazumdar Shaw only Indian woman in self-made billionaires listKiran Mazumdar Shaw started Biocon India in 1978 in the garage of her rented house in Bengaluru with a seed capital of Rs. 10,000.
- 'Donald Trump's push for lower drug prices to benefit Indian pharma'A Glenmark spokesperson said Indian pharma companies are known to offer products at lesser prices and it will look to address the rising dr...
- Shortage of ideas or funds? 'City's Visvesvaraya museum is way off global standards'“The museum authorities are wallowing in self-pity . They have a limited ability to understand what's best. It is a sad reflection of how m...
- Kiran Mazumdar-Shaw ranked no. 2 in power list of UK-based Medicine MakerMazumdar-Shaw has been ranked number two on The Medicine Maker Power List of 2015, an annual list which is compiled by UK-based The Medicin...
- Country's biggest Biotech annual event from February 9-11The Top Guns Talks is a Session where keynote address is delivered by the Global Leaders from Science & Industry sharing their Vision.
- Biocon chief Kiran Mazumdar-Shaw receives Othmer Gold Medal 2014Mazumdar-Shaw is the third woman to receive the Othmer Gold Medal and the first Indian to make it to this prestigious group.
- Biocon's oral insulin will take few more years to hit market: Kiran Mazumdar ShawBiocon my take a few more years to launch its oral insulin in the Indian market, said company's Chairman and Managing Director Kiran Mazumd...
- Strides inks pact with Malaysia's Bio-XCell for new facilityDrug firm Strides Arcolab said it has entered into an agreement with Bio-XCell Sdn Bhd for establishing a facility in Malaysia.
- Global biotech firms seek partnerships in India for bigger gainsThe global biotechnology industry is moving towards strategic partnerships in a bid to create faster and cost-efficient means of drug disco...
- Govt orders recall as Natco cancer drug fails toxin testThe drug regulator (DCGI) acted afer the US firm filed a written complaint citing serious side-effects that the generic may cause.
Load More
